Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer. Cho BC, Chiu CH, Massarelli E, Buchschacher GL, et al. Lung Cancer 2023;188:107442.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cho BC, Chiu CH, Massarelli E, Buchschacher GL, et al. Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer. Lung Cancer 2023;188:107442.
PMID: 38171156